JBJaroslaw Bogaczewicz

Jaroslaw Bogaczewicz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jaroslaw Bogaczewicz has a total of 44 co-authors. Here are the top co-authors by number of shared publications:

  • Anna Wozniacka

    Department of Dermatology and Venereology, Medical University of Lodz, Lodz, Poland

    7 shared publications
  • Anna Woźniacka

    Department of Dermatology and Venereology, Medical University of Lodz, 90-647 Lodz, Poland

    6 shared publications
  • Karolina Malinowska

    Med Univ Lodz, Dept Dermatol & Venereol, 1 Hallera St, PL-90647 Lodz, Poland

    5 shared publications
  • Jakub Zabek

    Department of Microbiology and Serology, Institute of Rheumatology, Warsaw, Poland

    4 shared publications
  • Anna Sysa-Jedrzejowska

    Department of Social Sciences, University of Social Sciences, Lodz, Poland

    3 shared publications
  • Jan Kowalski

    Department of Internal Diseases and Cardiological Rehabilitation, Medical University of Lodz, Lodz, Poland

    3 shared publications

Latest Publications

  • Open Access

    Gaming disorder: a narrative review

    by Anna Bogaczewicz, Jarosław Bogaczewicz

    Video games, including online ones, constitute very popular interactive entertainment, enjoyed non-problematically by many individuals worldwide. However, uncontrolled gaming and the occurrence of its negative consequences require appropriate diagnosis. Gaming disorder manifests as uncontrolled, persistent, or recurrent behaviour with gaming taking priority, despite its negative impact on personal functioning. Excessive use of the Internet unrelated to gaming, such as excessive use of social media, viewing pornography online, and internet gambling games, is excluded from the concept of disordered gaming. The worldwide prevalence is 3%, rising to 4.6% in adolescents, affecting more males than females. The pathogenesis is heterogeneous, with various psychological contributory factors, such as fascination with an alternative world and self-concept, low self-esteem, impulsivity, dysregulation of the reward system, and escapism. Individuals with reduced dopamine-receptor function are prone to developing disordered gaming, in particular under stressful life events. Imaging studies have demonstrated changes in brain activation, such as hyperactivation of the anterior cingulate cortex, dorsolateral prefrontal cortex, posterior inferior frontal gyrus, caudate, posterior cingulate cortex, and precuneus; in contrast to hypoactivation of the anterior inferior frontal gyrus, posterior insula, and precentral and postcentral gyri. With respect to psychiatric comorbidities, such as attention deficit hyperactivity disorder or major depressive disorder, several drugs have been effective in treating gaming disorder, namely bupropion, escitalopram, fluoxetine, paroxetine, methylphenidate, and atomoxetine. The most effective psychological intervention was cognitive-behavioural therapy. There is a need to conduct further randomised, double-blind studies controlling for comorbid mental disorders and carried out on larger groups of patients.


  • Interplay between IL-17 family members and angiogenic cytokines in subjects with systemic sclerosis.

    by Agata Liszewska, Ewa Robak, Anna Woźniacka, Jaroslaw Bogaczewicz, Bożena Dziankowska-Bartkowiak, Zofia Gerlicz-Kowalczuk

    Introduction: Systemic sclerosis (SSc) is a chronic, autoimmune connective tissue disease characterized by immune system activation, vasculopathy, and collagen accumulation. Despite progressive fibrosis of the vasculature, compensatory angiogenesis is impaired. The cause of the shift towards...

  • Open Access

    A medium dose of UVA1 phototherapy does not diminish vitamin D level in patients with atopic dermatitis

    by Małgorzata Bernacka, Anna Woźniacka, Karolina Malinowska, Jarosław Bogaczewicz

    Introduction Medium-dose UVA1 phototherapy is a widely used method in treatment in patients with atopic dermatitis. There are suggestions that UVA1 can decrease cutaneous production of vitamin D via photodegradation. Objective To determine whether a medium dose of UVA1 phototherapy decreases...

  • Open Access

    The impact of medium dose UVA1 phototherapy on pruritus, DLQI and SCORAD index in patients with atopic dermatitis

    by Karolina Malinowska, Anna Woźniacka, Jarosław Bogaczewicz

    Introduction Atopic dermatitis (AD) is featured by pruritus, which causes diminished quality of life. Little clinical data exists concerning the use, efficacy and side effects of UVA1 phototherapy in AD patients. Aim To determine the effectiveness of medium-dose UVA1 phototherapy in AD...


  • Open Access

    Changes of NADH Fluorescence from the Skin of Patients with Systemic Lupus Erythematosus

    by Jaroslaw Bogaczewicz, Kamila Tokarska, Anna Wozniacka

    Introduction. The blood circulation of the skin is an accessible and representative vascular bed for examining the mechanisms of microcirculatory function. Endothelial function is impaired in systemic lupus erythematosus (SLE), which implies disorders in cell metabolism dependent on blood circulation; however, noninvasive monitoring of metabolism at the tissue and cell level is absent in daily clinical practice.Objective. The aim of the study was to examine changes of NADH fluorescence from the epidermis of a forearm measured with the flow mediated skin fluorescence (FMSF) technique in patients with SLE and to investigate whether they are associated with clinical manifestation of the disease.Materials and Methods. The study enrolled 36 patients with SLE and 34 healthy individuals. Changes of NADH fluorescence were measured using FMSF on the forearm in response to blocking and releasing of blood flow. The results were represented as ischemic (IR max and IR auc) and hyperemic response maximum and area under the curve (HR max and HR auc).Results. IR max, IR auc, HR max, and HR auc were all lower in patients with SLE (p<0.05) compared with controls. All four parameters were negatively correlated (p<0.05) with patient age. No difference was found in NADH fluorescence between SLE patients with malar rash, discoid rash, photosensitivity, oral ulcers, nonerosive arthritis, renal disorder, hematologic disorder, or immunologic disorder and those without. No correlation was revealed between the SLEDAI score and NADH fluorescence.Conclusion. Changes of NADH fluorescence indicate the reduction in NADH restoration, observed especially during reperfusion, and suggest the occurrence of disorders in the microcirculation of the skin and/or at the mitochondrial level. Such changes of NADH during reperfusion in patients with SLE could be associated with their possible lower sensitivity to hypoxia and possibly with endothelial dysfunction.


  • Funkcje poznawcze a autoprzeciwciała u chorych na toczeń rumieniowaty układowy

    by Anna Bogaczewicz, Jakub Ząbek, Tomasz Sobów, Ewa Robak, Jarosław Bogaczewicz, Anna Woźniacka


  • Chloroquine-induced subacute paranoid-like disorder as a complication of dermatological treatment

    by Anna Bogaczewicz, Tomasz Sobow, Jaroslaw Bogaczewicz, Przemyslaw Bienkowski, Jan Kowalski, Anna Wozniacka


  • Medium‐dose ultraviolet A1 phototherapy improves SCORAD index and increases mRNA expression of interleukin‐4 without direct effect on human β defensin‐1, interleukin‐10, and interleukin‐31

    by Jaroslaw Bogaczewicz, Karolina Malinowska, Anna Sysa‐Jedrzejowska, Anna Wozniacka

    Background: Effectiveness of ultraviolet (UV)A1 in flares of atopic dermatitis (AD) is thought to influence the expression of cytokines involved in its pathogenesis. The aim of the study was to investigate whether mRNA expression of human β defensin‐1 (hβD‐1) correlates with that of interleukin (IL)‐4, IL‐10, and IL‐31 in skin lesions in AD before and after UVA1 phototherapy, to determine whether UVA1 decreases the expression of the aforementioned mediators, and to confirm whether changes in mRNA expression correspond with the clinical efficacy of UVA1.Methods: Twenty‐five patients with AD underwent medium‐dose UVA1 phototherapy. Before and after UVA1, biopsies from acute skin lesions were studied using reverse transcription and real‐time polymerase chain reaction.Results: Levels of mRNA hβD‐1 correlated with those of IL‐10 and IL‐31, levels of IL‐4 mRNA correlated with those of IL‐10 and IL‐31, and IL‐10 expression correlated with that of IL‐31, both before and after UVA1. Phototherapy with UVA1 improved SCORing of Atopic Dermatitis (SCORAD) values, decreased pruritus, and increased expression of IL‐4. After UVA1, no difference was found in the mRNA expression of other molecules. The SCORAD index did not correlate with the expression of any examined mRNA either before or after UVA1.Conclusions: hβD‐1, IL‐4, IL‐10, and IL‐31 are expressed in acute skin lesions in AD, and their levels correlate with each other. UVA1 improves SCORAD and pruritus and increases the expression of IL‐4 without direct effect on other molecules.


  • Open Access

    Medium dose ultraviolet A1 phototherapy and mRNA expression of interleukin 8, interferon γ, and chemokine receptor 4 in acute skin lesions in atopic dermatitis

    by Jarosław Bogaczewicz, Karolina Malinowska, Anna Sysa-Jedrzejowska, Anna Wozniacka

    Introduction : Mechanisms responsible for UVA1 efficacy in atopic dermatitis (AD) are not fully elucidated. Aim: To investigate IL-8, CCR-4, and IFN-γ mRNA expression in AD before and after UVA1, to identify correlations among them, and to determine whether and to what degree mRNA...


  • Requirement for vitamin D supplementation in patients using photoprotection: variations in vitamin D levels and bone formation markers

    by Jaroslaw Bogaczewicz, Elzbieta Karczmarewicz, Pawel Pludowski, Jakub Zabek, Anna Wozniacka

    Background: Avoiding sun exposure is obligatory in photodermatoses; however, the need for oral supplementation with vitamin D appears unrecognized. The aim of the study was to investigate the seasonal variation of vitamin D level and bone formation markers in healthy individuals and to compare it with vitamin D status in patients using photoprotection.Methods: Thirty‐four healthy inhabitants of the Lodz region, Poland, a country in central Europe (51° and 52° north latitudes), were examined at the baseline visit within 2 weeks of peak sun exposure during recreational activity on vacation, after 8, and after 16 weeks. The group of patients using photoprotection comprised 104 patients with systemic lupus erythematosus. Serum 25(OH) vitamin D, procollagen type I N‐terminal propeptide (PINP), and osteocalcin levels were measured.Results: The serum 25‐hydroxyvitamin D concentration was lower and vitamin D deficiency more common in patients using photoprotection than in healthy individuals during the warm and the cold season (P < 0.05). In healthy individuals, vitamin D deficiency was more prevalent after 8 and 16 weeks than at baseline assessment (P < 0.001). PINP level was 39.56 (30.51–53.22) ng/ml, and elevated in 50% of individuals, whereas osteocalcin was 18.88 (13.52–21.33) ng/ml, and within reference range.Conclusions: Diagnoses of vitamin D deficiency and oral supplementation in patients using photoprotection need to be included in practice. Peak 25‐hydroxyvitamin D levels are probably achieved from vitamin D skin synthesis during the summertime and fall over time, starting from August. Elevated levels of PINP appear in line with the process of bone remodeling related to age.